Phibro Animal Health | PAHC - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Align Technology USD 757.43M 20.84M 2026-06
ANI Pharmaceuticals USD 143.88M 19.7M 2026-03
Aurora Cannabis CAD 29.79M 16.83M 2026-03
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Canopy Growth CAD 8.26M 13.2M 2026-03
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Henry Schein USD 1.03B 39M 2026-06
Idexx Laboratories USD 779.09M 56.35M 2026-06
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Merck USD 12.09B 1.24B 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Pacira USD 133.91M 7.27M 2026-06
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 136.19M 10.11M 2026-06
Supernus Pharmaceuticals USD 160.06M 30.7M 2026-06
Zoetis USD 1.76B 140M 2026-06